ELECSYS ZIKA IGG
Mexico·Clase I·III. DIAGNOSTIC AGENTS·PRODUCTOS ROCHE, S.A. DEC.V.·Registered October 12, 2020PRUEBA INMUNOLÓGICA IN VITRO PARA LADETERMINACIÓN CUALITATIVA DEANTICUERPOSIGGFRENTEALVIRUSDELZIKAEN SUERO Y PLASMA HUMANOS.
IN VITRO IMMUNOLOGICAL TEST FOR THE QUALITATIVE DETERMINATION OF SIGGANTIG ANTIBODY AGAINST ZIKA VIRUS IN HUMAN SERUM AND PLASMA.
- Risk Class / Clase de Riesgo
- Clase I
- Product Type (Spanish)
- III. AGENTES DE DIAGNÓSTICO
- Product Type (English)
- III. DIAGNOSTIC AGENTS
- Trade Name (Spanish)
- PRUEBA PARA LA DETERMINACIÓNDEANTICUERPOSIGGDELVIRUSDELZIKA
- Trade Name (English)
- TEST FOR THE DETERMINATION OF SIGGDELZIKA VIRUS ANTIBODY
- Analysis ID
- 1399R2020 SSA
- Registration Date
- October 12, 2020
- Name (Spanish)
- PRODUCTOS ROCHE, S.A. DEC.V.
- Name (English)
- PRODUCTOS ROCHE, S.A. DEC.V.
Access comprehensive regulatory information for ELECSYS ZIKA IGG (ELECSYS ZIKA IGG) in the Mexico medical device market through Pure Global AI's free database. This Clase I medical device is registered under COFEPRIS analysis ID 1399R2020 SSA and manufactured by PRODUCTOS ROCHE, S.A. DEC.V.. The device was registered on October 12, 2020.
This page provides complete registration details including product type (III. DIAGNOSTIC AGENTS), manufacturer information, and regulatory compliance data from the official Mexico COFEPRIS medical device database. Pure Global AI offers free access to Mexico's complete medical device registry with bilingual Spanish/English support, helping global MedTech companies navigate COFEPRIS regulations efficiently.